D&D Pharmatech (347850.KQ)

KRW 51000.0

(5.48%)

Total Assets Summary of D&D Pharmatech

  • D&D Pharmatech's latest annual total assets in 2023 was 79.2 Billion KRW , down -15.42% from previous year.
  • D&D Pharmatech's latest quarterly total assets in 2024 Q2 was 109.52 Billion KRW , down 0.0% from previous quarter.
  • D&D Pharmatech reported annual total assets of 93.64 Billion KRW in 2022, down -62.71% from previous year.
  • D&D Pharmatech reported annual total assets of 251.1 Billion KRW in 2021, up 9.58% from previous year.
  • D&D Pharmatech reported quarterly total assets of 109.52 Billion KRW for 2024 Q2, down 0.0% from previous quarter.
  • D&D Pharmatech reported quarterly total assets of - KRW for 2023 Q1, down -100.0% from previous quarter.

Annual Total Assets Chart of D&D Pharmatech (2023 - 2019)

Historical Annual Total Assets of D&D Pharmatech (2023 - 2019)

Year Total Assets Total Assets Growth
2023 79.2 Billion KRW -15.42%
2022 93.64 Billion KRW -62.71%
2021 251.1 Billion KRW 9.58%
2020 229.16 Billion KRW -21.97%
2019 293.66 Billion KRW 0.0%

Peer Total Assets Comparison of D&D Pharmatech

Name Total Assets Total Assets Difference
HLB Co., Ltd. 751.72 Billion KRW 89.464%
iNtRON Biotechnology, Inc. 98.61 Billion KRW 19.684%
BINEX Co., Ltd. 257.01 Billion KRW 69.183%
Bioneer Corporation 315.48 Billion KRW 74.895%
Anterogen.Co.,Ltd. 149.43 Billion KRW 46.997%
MEDIPOST Co., Ltd. 449.39 Billion KRW 82.375%
CrystalGenomics, Inc. 243.11 Billion USD 67.421%
Helixmith Co., Ltd 227.27 Billion KRW 65.151%
Chabiotech Co.,Ltd. 1725.57 Billion KRW 95.41%
Medy-Tox Inc. 611.62 Billion KRW 87.05%
Peptron, Inc. 52.49 Billion KRW -50.876%
Amicogen, Inc. 467.09 Billion KRW 83.043%
Genexine, Inc. 376.58 Billion KRW 78.968%
HLB Therapeutics Co.,Ltd. 200.79 Billion KRW 60.555%
LegoChem Biosciences, Inc. 189.5 Billion KRW 58.204%
ALTEOGEN Inc. 256.09 Billion KRW 69.073%
PharmaResearch Co., Ltd. 535.28 Billion KRW 85.203%
SillaJen, Inc. 76.71 Billion KRW -3.244%
JETEMA, Co., Ltd. 252.14 Billion KRW 68.588%
OliX Pharmaceuticals,Inc 102.82 Billion KRW 22.972%
Genomictree Inc. 132.84 Billion KRW 40.378%
MedPacto, Inc. 80.47 Billion KRW 1.579%
EASY BIO,Inc. 172.04 Billion KRW 53.962%
GI Innovation, Inc. 81.34 Billion KRW 2.627%